Note: Ingredients listed on restricted chemical lists
EC/CAS
206-801-3/375-95-1
Name of the chemical
Perfluorononanoic acid (PFNA)
Concentration
>=90-<=100
General Information
Version
1.1
Revision date
2025-11-28
Product name
Heptadecafluorononanoic Acid
CAS No.
375-95-1
1.2.1 Relevant identified uses
Use as laboratory reagent
Emergency telephone
+44 844 892 0111
Icons in SDS
Company Information
company name
TCI EUROPE N.V
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H332, H314, H351, H360Df, H362, H372
Hazard statements
Code
Statements
H302+H332
Harmful if swallowed or if inhaled
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger
Hazard statements
H302 + H332 Harmful if swallowed or if inhaled. H314 Causes severe skin burns and eye damage. H351 Suspected of causing cancer. H360Df May damage the unborn child. Suspected of damaging fertili- ty. H362 May cause harm to breast-fed children. H372 Causes damage to organs (Liver, thymus, spleen) through prolonged or repeated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P263 Avoid contact during pregnancy and while nursing. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection.
Response
P303 + P361 + P353 IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water. P304 + P340 + P310 IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor. P308 + P313 IF exposed or concerned: Get medical advice/ atten- tion.
Additional information
Restricted to professional users
Other hazards
This substance/mixture contains components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB)
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupt- ing properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commis- sion Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine dis- rupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Com- mission Regulation (EU) 2018/605 at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4 H302: Harmful if swallowed. Acute toxicity, Category 4 H332: Harmful if inhaled. Skin corrosion, Sub-category 1C H314: Causes severe skin burns and eye damage. Serious eye damage, Category 1 H318: Causes serious eye damage. Carcinogenicity, Category 2 H351: Suspected of causing cancer. Reproductive toxicity, Category 1B H360Df: May damage the unborn child. Suspected of damaging fertility. Effects on or via lactation H362: May cause harm to breast-fed children. Specific target organ toxicity - repeated expo- H372: Causes damage to organs through prolonged or sure, Category 1, Liver, thymus, spleen repeated exposure.